Follow
Bhavana Bhatnagar
Bhavana Bhatnagar
West Virginia Cancer Institute
Verified email at hsc.wvu.edu
Title
Cited by
Cited by
Year
Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology
JP Radich, M Deininger, CN Abboud, JK Altman, E Berman, R Bhatia, ...
Journal of the National Comprehensive Cancer Network 16 (9), 1108-1135, 2018
2492018
Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
MW Deininger, NP Shah, JK Altman, E Berman, R Bhatia, B Bhatnagar, ...
Journal of the National Comprehensive Cancer Network 18 (10), 1385-1415, 2020
2312020
Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single†…
B Bhatnagar, S Gilmore, O Goloubeva, C Pelser, M Medeiros, S Chumsri, ...
Springerplus 3, 1-6, 2014
1392014
Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial
A El-Jawahri, TW LeBlanc, A Kavanaugh, JA Webb, VA Jackson, ...
JAMA oncology 7 (2), 238-245, 2021
1172021
XPO1 inhibition using selinexor synergizes with chemotherapy in acute myeloid leukemia by targeting DNA repair and restoring topoisomerase IIα to the nucleus
P Ranganathan, T Kashyap, X Yu, X Meng, TH Lai, B McNeil, ...
Clinical Cancer Research 22 (24), 6142-6152, 2016
872016
NCCN guidelines insights: chronic myeloid leukemia, version 1.2017
A Pallera, JK Altman, E Berman, CN Abboud, B Bhatnagar, P Curtin, ...
Journal of the National Comprehensive Cancer Network 14 (12), 1505-1512, 2016
722016
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
AS Kittai, DA Bond, B William, A Saad, S Penza, Y Efebera, K Larkin, ...
Blood Advances 4 (19), 4648-4652, 2020
682020
Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease†…
MR Litzow, Z Sun, E Paietta, RJ Mattison, HM Lazarus, JM Rowe, ...
Blood 140 (Supplement 2), LBA-1-LBA-1, 2022
652022
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
P Ranganathan, X Yu, R Santhanam, J Hofstetter, A Walker, K Walsh, ...
Blood, The Journal of the American Society of Hematology 125 (17), 2689-2692, 2015
652015
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
B Bhatnagar, AK Eisfeld, D Nicolet, K Mrůzek, JS Blachly, S Orwick, ...
British journal of haematology 175 (2), 226-236, 2016
622016
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy
B Bhatnagar, VH Duong, TS Gourdin, ML Tidwell, C Chen, Y Ning, ...
Leukemia & lymphoma 55 (7), 1533-1537, 2014
622014
NCCN guidelines insights: acute lymphoblastic leukemia, Version 1.2019: featured updates to the NCCN guidelines
PA Brown, M Wieduwilt, A Logan, DJ DeAngelo, ES Wang, A Fathi, ...
Journal of the National Comprehensive Cancer Network 17 (5), 414-423, 2019
602019
Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia
B Bhatnagar, J Kohlschmidt, K Mrůzek, Q Zhao, JL Fisher, D Nicolet, ...
Cancer discovery 11 (3), 626-637, 2021
522021
Complete responses in relapsed/refractory acute myeloid leukemia (AML) patients on a weekly dosing schedule of XmAb14045, a CD123 x CD3 T cell-engaging bispecific antibody†…
F Ravandi, A Bashey, JM Foran, W Stock, R Mawad, W Blum, MW Saville, ...
Blood 132, 763, 2018
522018
AML with myelodysplasia-related changes: development, challenges, and treatment advances
KL Koenig, KD Sahasrabudhe, AM Sigmund, B Bhatnagar
Genes 11 (8), 845, 2020
512020
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia
AR Walker, H Wang, K Walsh, B Bhatnagar, S Vasu, R Garzon, ...
Leukemia & lymphoma 57 (9), 2100-2108, 2016
482016
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
N Jain, W Stock, A Zeidan, E Atallah, J McCloskey, L Heffner, B Tomlinson, ...
Blood advances 4 (3), 449-457, 2020
472020
Entospletinib in combination with induction chemotherapy in previously untreated acute myeloid leukemia: response and predictive significance of HOXA9 and MEIS1 expression
AR Walker, JC Byrd, JS Blachly, B Bhatnagar, AS Mims, S Orwick, TL Lin, ...
Clinical Cancer Research 26 (22), 5852-5859, 2020
442020
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
B Bhatnagar, Q Zhao, AS Mims, S Vasu, GK Behbehani, K Larkin, ...
Leukemia & lymphoma 61 (2), 387-396, 2020
402020
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML
JY Jeon, Q Zhao, DR Buelow, M Phelps, AR Walker, AS Mims, S Vasu, ...
Investigational new drugs 38, 340-349, 2020
362020
The system can't perform the operation now. Try again later.
Articles 1–20